Special notice: For important updates about COVID-19 and its impact on CNSI facilities, please visit our COVID-19 guidance page.
Research priorities of the CNSI at UCLA build upon the work of our Members, over 150 leading faculty representing nearly 35 Departments. CNSI provides a unique collaborative atmosphere that leverages pooled talent and resources to address the most serious and perplexing questions of our time. The Institute facilitates powerful collaborations among world-class scientists in fields ranging from applied mathematics and engineering to the natural and biomedical sciences. By leveraging the Institute’s central location in the heart of UCLA’s Court of Sciences and proximity to UCLA’s David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, and Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, CNSI supports problem-based, team science initiatives in targeted areas.
Research priorities of the CNSI at UCLA build upon the work of our Members, over 150 leading faculty representing nearly 35 Departments. CNSI provides a unique collaborative atmosphere that leverages pooled talent and resources to address the most serious and perplexing questions of our time. The Institute facilitates powerful collaborations among world-class scientists in fields ranging from applied mathematics and engineering to the natural and biomedical sciences. By leveraging the Institute’s central location in the heart of UCLA’s Court of Sciences and proximity to UCLA’s David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, and Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, CNSI supports problem-based, team science initiatives in targeted areas:
Research Facilitation
The CNSI Grants Facilitation Team works to catalyze interactions between new and existing teams of researchers to develop collaborative proposals that cross disciplines and support the key research mission of the Institute. Our team offers organizational assistance including meeting scheduling, budget construction, editing, and writing assistance to meet submission deadlines with polished proposals in compliance with government, university, and sponsor regulations and requirements.
Research News
June 9, 2021 | Faster holographic imaging using recurrent neural networks
A research team at UCLA has recently developed a novel holographic phase retrieval technique that can rapidly reconstruct microscopic images of samples with up to 50-fold acceleration compared to existing methods. This new technique is taking advantage of recurrent...
June 1, 2021 | Soft Focus: A Flexible Future for Robots
A quintet of Hong’s faculty researchers at the UCLA Samueli School of Engineering are doing the early work to realize robots with an entirely different feel, literally — softer, more pliable and better suited for engaging with people....
May 26, 2021 | Biosolids used as fertilizer could contain more plastic than previously thought
A study by UCLA scientists raises a concern about the makeup of some of the fertilizer being used on crops, gardens and landscaping. A portion of the fertilizer used in the U.S. and around the world comes from a source you might not expect: wastewater treatment...
May 11, 2021 | Gene therapy offers potential cure to children born without an immune system
An experimental form of gene therapy developed by a team of researchers from UCLA and Great Ormond Street Hospital in London has successfully treated 48 of 50 children born with a rare and deadly inherited disorder that leaves them without an immune system.[xyz-ips...
University of California Drug Discovery Consortium – Call for Seed Grant Applications
The University of California Drug Discovery Consortium (UC DDC) is a Cross campus initiative created by the UC BRAID D4 (Drugs, Devices, Diagnostics Development) group. The UC DDC currently receives funding from both the UC Office of the President and from Industry...
April 19, 2021 | Team led by UCLA professor wins $7.5 million NRG COSIA Carbon XPRIZE
A group of UCLA engineers has become the first university team to win the grand prize in the NRG COSIA Carbon XPRIZE global competition. By mitigating the carbon footprint of concrete, the team’s invention could eventually be a major step in the global battle against...
April 8, 2021 | CNSI experts examine COVID-19 vaccine efforts
As COVID-19 inoculation efforts continue to ramp up in the U.S. and around the world, two leaders at the California NanoSystems Institute at UCLA recently took stock of the unprecedented success of vaccine design efforts, as well as the challenges ahead. [xyz-ips...
March 30, 2021 | UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect
Scientists at UCLA, UC San Francisco and UC Berkeley have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patients’...
March 30, 2021 | Merck KGaA’s ATR Inhibitor Shows Promise in Both Cancer and COVID-19
A research collaboration among UCLA investigators and Merck KGaA, has pointed to the drug as showing promise for COVID-19. It is also being touted for its unusually broad effect in treating a range of cancers. Merck KGaA's ATR Inhibitor...
Give to Support a Brighter Future through Nanoscience and Nanotechnology
Your generous support of the California NanoSystems Institute at UCLA will drive innovations that address society’s most urgent challenges and give life to promising ideas for a prosperous future together.